Running Point Capital Advisors, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Running Point Capital Advisors, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$34,000
-38.2%
10,0000.0%0.02%
-41.7%
Q3 2022$55,000
+22.2%
10,0000.0%0.04%
+24.1%
Q2 2022$45,000
-39.2%
10,0000.0%0.03%
-32.6%
Q1 2022$74,00010,0000.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders